Hepatitis C - screening serology - serum
Back to the listEurofins Biomnis code
HCVAC
Synonyms
- Anti-hepatitis C antibodies - screening test
- HCV - screening serology
Specialty
Infectious
Clinical significance
HCV belongs to the family of Flaviviridae and is parenterally transmitted. In France, at least 600,000 people are believed to be infected. The acute phase of the resultant hepatitis is often asymptomatic or atypical but chronic infection becomes established in over 50% of cases. Of these, one in five will develop cirrhosis which can lead to hepatocellular carcinoma. HCV represent a global public health problem. Diagnosis depends on serological analysis. Immunoblotting (RIBA) is of little practical relevance. Viral activity can be monitored most simply by measuring transaminase activity with, if necessary, PCR assay of viral RNA in the serum which is the most sensitive, currently available, technique and which is ideal for monitoring the efficacy of treatment (i.e. the disappearance of viral RNA). Quantitative measurement of the viral load using the PCR assay or the b-DNA technique can be helpful in deciding whether or not to undertake treatment and for monitoring its efficacy. Determining the genotype of the particular virus can be useful for predicting efficacy and for deciding which drugs and what dose to prescribe It is well established that the chance of success is lower with genotype 1b.
Methodology
Chemiluminescence
Turnaround time
2 days
Biomnis Ivry